Physiologically Based Pharmacokinetic (PB/PK) and Quantitative Systems Pharmacology (QSP) Modelling at the centre stage. FDA announced to reduce animal testing in preclinical safety studies with PB/PK and QSP.
Visit us at the Swiss Biotech Day 2025 from May 5-6, booth 67 to learn more on how to navigate the new regulatory changes in your preclinical antibody development programs.
See you in Basel!